Home
Market Capitalization of Glaxosmithkline Pharmaceuticals Ltd

Glaxosmithkline Pharmaceuticals Ltd
NSE: GLAXO
Market Cap
Key Highlights
- The Market Cap of Glaxosmithkline Pharmaceuticals Ltd is ₹ 42500 crore as of 21 Feb 25 .
- The Latest Trading Price of Glaxosmithkline Pharmaceuticals Ltd is ₹ 2508 as of 21 Feb 15:30 .
- The Dividend Payouts of Glaxosmithkline Pharmaceuticals Ltd changed from ₹ 30 on Jul 19, 2021 to ₹ 12 on Nov 07, 2024 . This represents a CAGR of -14.16% over 6 years.

Glaxosmithkline Pharmaceuticals Ltd
NSE: GLAXO
Share Price
Market Price of Glaxosmithkline Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 2508.8 |
20 Feb 2025 | 2569.45 |
19 Feb 2025 | 2510.2 |
18 Feb 2025 | 2529.7 |
17 Feb 2025 | 2332.25 |
14 Feb 2025 | 2017.75 |
13 Feb 2025 | 1995.65 |
12 Feb 2025 | 2031.5 |
11 Feb 2025 | 2056.25 |
10 Feb 2025 | 2141.55 |
SWOT Analysis Of Glaxosmithkline Pharmaceuticals Ltd
BlinkX Score for Glaxosmithkline Pharmaceuticals Ltd
Asset Value vs Market Value of Glaxosmithkline Pharmaceuticals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Glaxosmithkline Pharmaceuticals Ltd
Historical P/E Ratio of Glaxosmithkline Pharmaceuticals Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Glaxosmithkline Pharmaceuticals Ltd
Historical Revenue of Glaxosmithkline Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Glaxosmithkline Pharmaceuticals Ltd
Historical EBITDA of Glaxosmithkline Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Glaxosmithkline Pharmaceuticals Ltd
Historical Net Profit of Glaxosmithkline Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Glaxosmithkline Pharmaceuticals Ltd
Historical Dividend Payouts of Glaxosmithkline Pharmaceuticals Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payouts of Glaxosmithkline Pharmaceuticals Ltd
About Glaxosmithkline Pharmaceuticals Ltd
- GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc., a global biopharma company to unite science, technology and talent to get ahead of disease together.
- The Company is headquartered in Mumbai and it has six branch offices, a manufacturing facility at Nashik in Maharashtra, 22 contract manufacturing organisations (CMOs) with regional and sales hubs across India.
- The Company is engaged interalia, in the business of manufacturing, distributing and trading in pharmaceuticals. The Company's portfolio includes General Medicines, Vaccines and Specialty medicines that help prevent and treat disease.
- Their prescription medicines range across therapeutic areas, such as Anti-Infectives, Dermatology, Gynaecology, Diabetes, Oncology, Cardiovascular Disease and Respiratory Diseases.
Glaxosmithkline Pharmaceuticals Ltd News Hub
Glaxosmithkline Pharmaceuticals consolidated net profit rises 37.87% in the June 2024 quarter
Net profit of Glaxosmithkline Pharmaceuticals rose 37.87% to Rs 182.33 crore in the quarter ended Ju
Read more
05 Aug 24
GSK Pharma Q1 PAT climbs 39% YoY to Rs 182 crore
Revenue from operations grew by 9.89% year on year (YoY) to Rs 811 crore during the quarter ended Ju
Read more
03 Aug 24
GlaxoSmithKline Pharmaceuticals to declare Quarterly Result
GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 O
Read more
25 Oct 24
Board of GlaxoSmithKline Pharmaceuticals recommends Special Interim Dividend
GlaxoSmithKline Pharmaceuticals announced that the Board of Directors of the Company at its meeting
Read more
29 Oct 24